Education and demonstration – Detection or range determination of distant object by... – Radar
Reexamination Certificate
2007-08-14
2007-08-14
Campell, Bruce R. (Department: 1648)
Education and demonstration
Detection or range determination of distant object by...
Radar
C435S235100, C435S193000
Reexamination Certificate
active
10831939
ABSTRACT:
The invention provides a method for detecting the presence of altered serum proteins in an Hepatitis B Virus (HBV)-infected patient with liver inflammation, comprising: obtaining a sample of serum from the patient; subjecting the sample to protein gel electrophoresis to separate proteins contained therein; staining proteins separated on the electrophoresis gel with silver nitrate solution; scanning the images of stained proteins into an image analysis scanner to obtain gel images; comparing the gel images to control samples of electrophoresis gels prepared from serum of normal patient and serum of HBV-infected patient with liver inflammation to determine whether the sample of serum from the patient contains specific serum proteins. This invention also provides serum protein biomarkers for the diagnosis of patients with HBV infection and liver inflammation.
REFERENCES:
Berggren K. et al “Background-free, high sensitivity staining of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex”. Electrophoresis. Jul. 2000;21(12):2509-21.
Steel L et al. “A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma”, Dis Markers. 2001;17(3):179-89. Review.
Huang W & Gong FY “Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus.” Di Yi Jun Yi Da Xu Xu Bao Nov. 2002,; 22(11). Abstract.
Gong Fy, Huang W.;Diagnostic Value of Serum Biochemical Markers for Liver Fibrosis in Patients with Hepatitis B. Virus;PMID: 12433643 [PubMed—indexed for MEDLINE] (2002)22:1034-6.
Berggren, Kiera et al.;Background-free, High Sensitivity Staining of Proteins in One-and Two Dimensional Sodium Dodecyl Sulfate-Polyacrylamide Gels Using a Luminescent Ruthenium Complex; Electrophoresis 21 (2000) 2509-2521.
Steel, Laura F. et al.;A Proteomic Approach for the Discovery of Early Detection Markers of Hepatocellular Carcinoma; Disease Markers 17 (2001) 179-189.
Chen, Chien-Jen et al.;Towards Control of Hepatitis B in the Asia-Pacific Region; Journal of Gastroenterology and Hepatology (2000) 15 (Suppl.) E3-E6.
Feitelson, M.A.;The Pathogenesis of Chronic Hepatitis B Virus Infection; Bull. Inst. Pasteur 96 (1998) 227-236.
Chen, Henry Lik-Yuen;Changing scene in Hepatitis B Serology Interpretation; Hospital Medicine, January 63 (2002) No. 1.
Lau, George KK;Hepatitis B. Infection in China; Clinics in Liver Disease vol. 5 No. 2 May 2001.
He, Qing-Yu, et al.;Serum Biomakers of Hepatitis B Virus Infected Liver Inflammation: A Proteomic Study; Proteomics 3 (2003) 666-674.
Buendia, MA;Hepatitis B Viruses and Cancerogenesis; Biomed & Pharmacother 52 (1998) 34-43.
Chiu Jen-Fu
He Qing-Yu
Lau George
Zhou Yuan
Campell Bruce R.
Cooper & Dunham LLP
Katz Robert D.
Peng Bo
The University of Hong Kong
LandOfFree
Serum biomarkers of Hepatitis B Virus infected liver and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serum biomarkers of Hepatitis B Virus infected liver and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serum biomarkers of Hepatitis B Virus infected liver and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3842108